1. Home
  2. GILT vs MBX Comparison

GILT vs MBX Comparison

Compare GILT & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • MBX
  • Stock Information
  • Founded
  • GILT 1987
  • MBX 2018
  • Country
  • GILT Israel
  • MBX United States
  • Employees
  • GILT N/A
  • MBX N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • MBX
  • Sector
  • GILT Technology
  • MBX
  • Exchange
  • GILT Nasdaq
  • MBX NYSE
  • Market Cap
  • GILT 400.3M
  • MBX 300.5M
  • IPO Year
  • GILT 1993
  • MBX 2024
  • Fundamental
  • Price
  • GILT $6.52
  • MBX $11.11
  • Analyst Decision
  • GILT Strong Buy
  • MBX Strong Buy
  • Analyst Count
  • GILT 2
  • MBX 5
  • Target Price
  • GILT $8.50
  • MBX $37.40
  • AVG Volume (30 Days)
  • GILT 178.0K
  • MBX 333.6K
  • Earning Date
  • GILT 05-19-2025
  • MBX 05-16-2025
  • Dividend Yield
  • GILT N/A
  • MBX N/A
  • EPS Growth
  • GILT 6.30
  • MBX N/A
  • EPS
  • GILT 0.44
  • MBX N/A
  • Revenue
  • GILT $305,448,000.00
  • MBX N/A
  • Revenue This Year
  • GILT $45.29
  • MBX N/A
  • Revenue Next Year
  • GILT $11.74
  • MBX N/A
  • P/E Ratio
  • GILT $14.96
  • MBX N/A
  • Revenue Growth
  • GILT 14.79
  • MBX N/A
  • 52 Week Low
  • GILT $4.04
  • MBX $4.81
  • 52 Week High
  • GILT $8.05
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • GILT 55.25
  • MBX N/A
  • Support Level
  • GILT $6.29
  • MBX N/A
  • Resistance Level
  • GILT $6.73
  • MBX N/A
  • Average True Range (ATR)
  • GILT 0.17
  • MBX 0.00
  • MACD
  • GILT 0.05
  • MBX 0.00
  • Stochastic Oscillator
  • GILT 66.67
  • MBX 0.00

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: